Overview
- Description
Developer of a medical device designed to modify human plasma to improve treatment for massive bleeding. The company's device effectively removes pepsinogen, a specific protein related to the fibrinolytic system, from blood plasma to prevent massive bleeding as well as contains a module unit that can be incorporated in conventional apheresis systems, craeted to remove key factors of the fibrinolytic system, enabling healthcare professionals to receive blood and plasma products with enhanced coagulation properties for improved treatment of excessive bleeding.
- Website
- Country
- Israel